![Huw Jones](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Huw Jones
Vorstandsvorsitzender bei
THERACRYF PLC
Vermögen: 16 799 $ am 31.05.2026
Profil
Huw Jones currently works at TheraCryf Plc, as Chief Executive Officer & Executive Director from 2020, Chronos Therapeutics Ltd., as Chairman, and OBN (UK) Ltd., as Non-Executive Director.
Dr. Jones also formerly worked at Sinclair Pharma UK Ltd., as Non-Executive Chairman from 2002 to 2006, Ardana Plc, as Non-Executive Director from 2006 to 2010, Ixaka Ltd., as Non-Executive Director, and CV Therapeutics, Inc., as President.
Dr. Jones received his doctorate degree from the University of Birmingham.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
THERACRYF PLC 0.24% | 31.03.2025 | 5’184’793 ( 0.24% ) | 16 799 $ | 31.05.2026 |
Aktive Positionen von Huw Jones
| Unternehmen | Position | Beginn |
|---|---|---|
| THERACRYF PLC | Vorstandsvorsitzender | 01.10.2020 |
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Vorsitzender | - |
OBN (UK) Ltd.
 OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a membership organization that supporting and bringing together the UK’s innovative life sciences companies, corporate partners and investors | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Huw Jones
| Unternehmen | Position | Ende |
|---|---|---|
Sinclair Pharma UK Ltd.
 Sinclair Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Provides co-promotional products and services in the pharmaceutical industry | Vorsitzender | 01.01.2006 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Präsident | - |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Direktor/Vorstandsmitglied | - |
Ardana Plc
 Ardana Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Vorstandsvorsitzender | - |
Ausbildung von Huw Jones
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Health Technology |
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sinclair Pharma UK Ltd.
Sinclair Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Provides co-promotional products and services in the pharmaceutical industry | Commercial Services |
OBN (UK) Ltd.
OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a membership organization that supporting and bringing together the UK’s innovative life sciences companies, corporate partners and investors | Commercial Services |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Health Technology |
